References
- Ongkeko WM, Altuna X, Weisman RA, et al. Expression of protein tyrosine kinases in head and neck squamous cell carcinomas. Am J Clin Pathol. 2005;124:71–76.
- Kontic M, Milovanovic J, Colovic Z, et al. Epidermal growth factor receptor (EGFR) expression in patients with laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2015;272:401–405.
- Lee JW, Soung YH, Kim SY, et al. Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2005;11:2879–2882.
- Almadori G, Cadoni G, Cattani P, et al. Human papillomavirus infection and epidermal growth factor receptor expression in primary laryngeal squamous cell carcinoma. Clin Cancer Res. 2001;7:3988–3993.
- Demiral AN, Sarioglu S, Birlik B, et al. Prognostic significance of EGF receptor expression in early glottic cancer. Auris Nasus Larynx. 2004;31:417–424.
- Rucci L, Bocciolini C, Franchi A, et al. Epidermal growth factor receptor and p53 expression in T1–T2 glottic cancer involving the anterior or posterior commissure. Acta Oto-laryngol. 2004;124:102–106.
- Bossi P, Resteghini C, Paielli N, et al. Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma. Oncotarget. 2016;7:5342059.
- Almadori G, Cadoni G, Galli J, et al. Epidermal growth factor receptor expression in primary laryngeal cancer: an independent prognostic factor of neck node relapse. Int J Cancer. 1999;84:188–191.
- Li Q, Chen Y, Kong P, et al. Correlation between the expression of HER-2/neu, nm23 protein and local invasion and lymph node metastasis of human LSCC. Lin chuang er bi yan hou ke za zhi = J Clin Otorhinolaryngol. 2006;20:259–261.
- Hardisson D. Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2003;260:502–508.
- Jiang M, Zhang H, Xiao H, et al. High expression of c-Met and EGFR is associated with poor survival of patients with glottic laryngeal squamous cell carcinoma. Oncol Lett. 2018;15:931–939.
- Krecicki T, Jelen M, Zalesska-Krecicka M, et al. Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions. Oral Oncol. 1999;35:180–186.
- Tong F, Geng J, Yan B, et al. Prevalence and prognostic significance of HPV in laryngeal squamous cell carcinoma in Northeast China. Cell Physiol Biochem. 2018;49:206–216.
- Vlachtsis K, Nikolaou A, Markou K, et al. Clinical and molecular prognostic factors in operable laryngeal cancer. Eur Arch Otorhinolaryngol. 2005;262:890–898.
- Pivot X, Magne N, Guardiola E, et al. Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer. Oral Oncol. 2005;41:320–327.
- Deeb G, Wang J, Ramnath N, et al. Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry. Mod Pathol. 2004;17:430–439.
- Peralta R, Garcia P, Valdivia A, et al. HPV could be a potential factor of survival in laryngeal cancer: a preliminary study in Mexican patients. Asian Pac J Cancer Prev: APJCP. 2018;19:1711–1716.
- Gao J, Ulekleiv CH, Halstensen TS. Epidermal growth factor (EGF) receptor-ligand based molecular staging predicts prognosis in head and neck squamous cell carcinoma partly due to deregulated EGF-induced amphiregulin expression. J Exp Clin Cancer Res. 2016;35:151.